based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts offering long term price targets for Hikal Ltd. An average target of ₹425
Source: S&P Global Market Intelligence
Hikal Ltd price forecast by 2 analysts
Upside of10.72%
High
₹430
Target
₹425.00
Low
₹420
Hikal Ltd target price ₹425, a slight upside of 10.72% compared to current price of ₹381.8. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Hikal Ltd revenue growth forecast
Expected growth rate Q1, FY2026:26.69%
Forecast
Actual
Including amortisation and stock based compensations
Hikal Ltd EPS growth forecast
EPS estimate Q1, FY2026:127.84%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 11.34 % |
3 Month Return | + 19.08 % |
1 Year Return | + 38.57 % |
Market Stats | |
Previous Close | ₹383.85 |
Open | ₹383.85 |
Volume | 1.87L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4,732.90Cr |
P/E Ratio | 69.79 |
PEG Ratio | -32.77 |
Market Cap | ₹4,732.90 Cr |
P/B Ratio | 2.75 |
EPS | 5.64 |
Dividend Yield | 0.45 |
Sector | Pharmaceuticals |
ROE | 5.99 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹4,732.90 Cr | 46.58% | 0.72 | ₹69 Cr | ₹1,784 Cr | |
HOLD | ₹33,703.13 Cr | 137.12% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
BUY | ₹19,854.36 Cr | 33.47% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
NA | ₹6,965.21 Cr | 6.09% | 0.79 | -₹388 Cr | ₹75 Cr | |
BUY | ₹15,940.57 Cr | 49.73% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Organisation | Hikal Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Hikal Ltd
Sugandha Hiremath alleges that her brother attempted to usurp the family's wealth and control over the company, leading to legal action in Pune court.
Hikal Ltd Faces Speculation Amid Family Dispute - 19 Sep, 2024
Hikal Ltd's stability is questioned following Baba Kalyani's resignation as a non-executive director, linked to ongoing family disputes. ICRA notes operations remain stable but will monitor developments closely.
Hikal Shareholders Approve Board Reappointment - 18 Sep, 2024
Hikal Ltd shareholders have approved the reappointment of Sugandha Hiremath to the board, with 50.6% votes in favor amid ongoing tensions between two promoter factions.
Hikal Shareholders Approve Reappointment of Director - 17 Sep, 2024
Hikal shareholders approved the reappointment of Sugandha Hiremath despite opposition, with 56.87% votes in favor. Other resolutions, including interim dividend and appointing a new independent director, were also approved.
Hikal Ltd Control Transferred to Sugandha Hiremath - 16 Sep, 2024
In a significant family dispute, control of Hikal Ltd has been given to Sugandha Hiremath, a director at the company, by her parents.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 2.73% to 3.22% in Sep 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 6.67% to 6.78% in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.4% return, outperforming this stock by 154.9%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.85% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 71.0% return, outperforming this stock by 32.5%
Retail Holding Down
Retail Investor have decreased holdings from 21.32% to 20.79% in Sep 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 514.7 Cr → 407.3 Cr (in ₹), with an average decrease of 20.9% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 33.9 Cr → 5.1 Cr (in ₹), with an average decrease of 85.0% per quarter
Price Dip
In the last 3 years, HIKAL stock has moved down by -26.5%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 68.85% | 0.00 | |
Foreign Institutions | 6.78% | 1.73 | |
Mutual Funds | 3.22% | 17.85 | |
Retail Investors | 20.79% | ||
Others | 0.36% |
Hikal Ltd in the last 5 years
Lowest (8.33x)
March 24, 2020
Industry (57.15x)
November 6, 2024
Today (69.79x)
November 6, 2024
Highest (81.58x)
January 3, 2023
Hikal Ltd’s net profit fell -26.09% since last year same period to ₹5.10Cr in the Q1 2024-2025. On a quarterly growth basis, Hikal Ltd has generated -84.96% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Hikal Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.47%.
Read More about DividendsBearish
Neutral
Bullish
Hikal Ltd is currently in a Bullish trading position according to technical analysis indicators.
Hikal Ltd (HIKAL) share price today is ₹381.8
Hikal Ltd is listed on NSE
Hikal Ltd is listed on BSE
PE Ratio of Hikal Ltd is 69.79
PE ratio = Hikal Ltd Market price per share / Hikal Ltd Earnings per share
Today’s traded volume of Hikal Ltd(HIKAL) is 1.87L.
Today’s market capitalisation of Hikal Ltd(HIKAL) is ₹4732.9Cr.
Hikal Ltd(HIKAL | Price |
---|---|
52 Week High | ₹410.9 |
52 Week Low | ₹260.3 |
Hikal Ltd(HIKAL) share price is ₹381.8. It is down -7.08% from its 52 Week High price of ₹410.9
Hikal Ltd(HIKAL) share price is ₹381.8. It is up 46.68% from its 52 Week Low price of ₹260.3
Hikal Ltd(HIKAL | Returns |
---|---|
1 Day Returns | -2.05% |
1 Month Returns | 11.34% |
3 Month Returns | 19.08% |
1 Year Returns | 38.57% |